AI and Neuroethics: The Questions Technology Companies Are Not Asking

## The Questions Nobody in the Room Is Asking

Every major technology wave has produced the same pattern: deployment first, ethical reckoning later. Social media moved fast and fractured public discourse. Algorithmic recommendation systems optimised for engagement and amplified extremism. AI-generated content challenged the epistemic foundations of shared reality.

Now neurotechnology is approaching the same inflection point — and the scale of the ethical stakes is categorically higher. When the interface is the human brain, the questions about power, consent, and manipulation are not abstract. They are questions about the nature of thought itself. For a broader overview of this space, visit our NeuroTechnology hub.

Deep Dive: The Questions Companies Building Neural Tech Refuse to Ask

What Is Neuroethics and Why It Matters Now

Neuroethics is the field that examines the ethical, legal, social, and philosophical implications of neuroscience and neurotechnology. It has existed as an academic discipline since the early 2000s. What has changed is urgency.

For most of its history, neuroethics was prospective — thinking carefully about technologies that were years or decades away. In 2026, those technologies are here. Neuralink has implanted devices in humans. Non-invasive BCIs are sold as consumer products. Neural data is being collected, stored, and processed at scale by private companies with primarily commercial incentives.

The gap between where the technology is and where the ethical frameworks are is not academic. It is operational. Decisions being made today about neural interface design, data collection practices, and algorithmic inference from brain signals will have consequences that outlast any regulatory response currently being drafted.

Cognitive Liberty: The Right You Did Not Know You Had

Cognitive liberty is the fundamental right to mental self-determination — the right to control your own cognitive processes, to think without surveillance, and to decline neurotechnology without consequence.

The concept was developed by neurorights scholar Rafael Yuste and legal theorist Nita Farahany, among others. It encompasses:

● The right to mental privacy — Your thoughts are yours. No technology should be able to read, infer, or transmit cognitive content without your explicit, informed, and ongoing consent.

● The right to cognitive autonomy — You control your own cognitive processes. No external system should be able to alter your thoughts, emotions, or cognitive states without your consent — including systems that claim to be helping.

● The right to mental integrity — Your brain should not be subject to unauthorised manipulation, stimulation, or disruption by external actors.

● The right to psychological continuity — Your sense of self, your memories, and your cognitive character should not be altered without your consent by external intervention.

These rights are not yet legally enshrined in most jurisdictions. Chile became the first country to enshrine neurorights in its constitution in 2021. Most countries have not followed.

Mental Privacy: The Right to Thoughts That Are Not Surveilled

The most immediate ethical concern with consumer BCIs is not dramatic brain hacking. It is the far more mundane reality of continuous neural surveillance.

A consumer EEG device worn during work hours collects data that can be used to infer:

• Attention and focus levels — when you are engaged vs distracted
• Emotional states — stress, frustration, boredom, excitement
• Cognitive load — how hard a task is for you
• Responses to content — what captures your attention and what does not

None of this requires invasive electrodes. It is inferable from consumer-grade non-invasive BCIs already on the market. These privacy risks are further analyzed in our post on Neural Data Privacy and Brain Activity Law.

The ethical question is not whether this inference is technically possible — it is. The questions are:

• Should employers be permitted to monitor this data from workers wearing BCIs?
• Should advertisers be permitted to target based on inferred neural states?
• Should insurance companies be permitted to adjust premiums based on cognitive performance data?
• Should governments be permitted to use neural surveillance in security contexts?

The answers to these questions are not being debated in boardrooms. They are being pre-answered by product design decisions made without ethical review.

Neural Manipulation: The Line Between Therapy and Control

Therapeutic neurostimulation has clear ethical grounding — deep brain stimulation for Parkinson's disease, neurofeedback for ADHD, transcranial magnetic stimulation for treatment-resistant depression. The intent is restoration of function. Consent is informed. Clinical oversight exists.

The ethical terrain becomes far more complex when the same technologies are applied outside clinical contexts:

Performance optimisation without clinical indication

• Cognitive enhancement through neurostimulation for healthy individuals
• tDCS devices marketed to improve focus, memory, or learning in consumers
• Military applications of cognitive enhancement stimulation without full informed consent

Algorithmic emotional regulation

• Closed-loop BCI systems that detect emotional states and automatically intervene to modulate them
• The boundary between emotional support and emotional control is defined entirely by the system designer

Attention manipulation at scale

• If a BCI can measure attention, can it also be used by content platforms to optimise content for maximum neural engagement rather than user benefit?
• The attention economy already distorts human cognition through behavioural design. Neural interfaces would give it a direct line into brain physiology.

The consent problem

Meaningful informed consent for neural interventions requires that users understand what is being done to their neural states, what inferences are being drawn, and what interventions are being applied — in real time, in terms that are cognitively accessible while the intervention is occurring. This is structurally difficult to achieve and has not been seriously attempted by any current consumer BCI company.

Who Is Setting Neuroethics Standards — and Who Is Not in the Room

Academic and research institutions — The work of bioethicists, neuroscientists, and legal scholars is producing frameworks. The Neurorights Foundation, Hastings Center, and academic neuroethics programmes are developing principles that increasingly inform policy.

International bodies — UNESCO's Recommendation on the Ethics of Neurotechnology (2024) established principles including mental integrity, cognitive liberty, and equitable access. The Council of Europe has neurotechnology ethics guidelines. The IEEE Standards Association has working groups on neural interface ethics.

Governments — Chile, Mexico, Brazil, Spain, and California have introduced neurorights legislation. The EU AI Act provides indirect governance. US federal frameworks are emerging slowly.

Who is not in the room:

• The companies building and selling the technology — present in standards bodies but not bound by the outputs
• Neurotechnology users — the people whose brains the technology interfaces with are rarely meaningfully consulted in standards development
• People from the Global South — the communities most likely to be subject to dual-use neurotechnology applications without the regulatory protection available in wealthy countries
• Future generations — the ethical implications of neural interface normalisation affect people who are not yet born

The Power Asymmetry Problem

At its core, every neuroethics concern reduces to a power asymmetry. On one side: a corporation with full visibility into a user's neural states, the engineers to interpret that data, the algorithms to act on it, and the legal resources to defend that position. On the other: a user who agreed to terms of service they did not read, wearing a device they do not fully understand, generating data whose implications they cannot assess.

This asymmetry is not unique to neurotechnology. But when the subject of the asymmetry is the human brain, the stakes are categorically higher than for any previous technology.

Conclusion

The companies building neural interfaces are not necessarily acting in bad faith. Most are genuinely trying to build useful technology. But good intentions do not substitute for ethical frameworks, and the history of technology development suggests that waiting for companies to self-regulate is not a viable strategy.

The questions that neuroethics asks are not comfortable ones for any industry to answer: What gives you the right to access someone's neural states? What are you doing with what you find? What happens when your incentives and theirs diverge?

These questions need to be asked — loudly, repeatedly, and in rooms where the people building the technology are present. The alternative is a repeat of the social media era, at a scale of intimacy that makes algorithmic manipulation of newsfeeds look trivial.

The brain is not just another interface. Treat it accordingly.

Frequently Asked Questions

---

Comparative Reference: Neuroethics Framework for AI-Brain Interfaces

Framework: Ienca & Andorno (2017), adapted with 2026 landscape analysis